Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 10, 2023
Real-life after sacral nerve modulation implantation: Rate, reasons, and risk factors for mid-term follow-up discontinuation
O Puyuelo, D Seguier, T Bommelaere, et al.
Revue Neurologique
|
February 15, 2023
NUTRISEP: Assessment of the nutritional status of patients with multiple sclerosis and link to fatigue
C Donzé, C Massot, G Defer, et al.
Neurology
|
April 24, 1999
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
A Delacourte, J P David, N Sergeant, et al.
La Revue De Medecine Interne
|
May 15, 2012
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus]
G Lefèvre, H Zéphir, F Warembourg, et al.
European Journal of Neurology
|
February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in Europe
O Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology
|
January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management
O Fernández, M Delvecchio, G Edan, et al.
Revue Neurologique
|
September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria
J Ciron, A Gueguen, A Al Khedr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
C Papeix, J-S Vidal, J de Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
S Cook, P Vermersch, G Comi, et al.
La Revue De Medecine Interne
|
May 15, 2012
[Neuropsychiatric systemic lupus erythematosus (2nd part). Diagnostic and treatment tools in psychiatric or central nervous system manifestations in systemic lupus erythematosus]
G Lefèvre, H Zéphir, E Michelin, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 10, 2023
Real-life after sacral nerve modulation implantation: Rate, reasons, and risk factors for mid-term follow-up discontinuation
O Puyuelo, D Seguier, T Bommelaere, et al.
Revue Neurologique
|
February 15, 2023
NUTRISEP: Assessment of the nutritional status of patients with multiple sclerosis and link to fatigue
C Donzé, C Massot, G Defer, et al.
Neurology
|
April 24, 1999
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
A Delacourte, J P David, N Sergeant, et al.
La Revue De Medecine Interne
|
May 15, 2012
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus]
G Lefèvre, H Zéphir, F Warembourg, et al.
European Journal of Neurology
|
February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in Europe
O Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology
|
January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management
O Fernández, M Delvecchio, G Edan, et al.
Revue Neurologique
|
September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria
J Ciron, A Gueguen, A Al Khedr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
C Papeix, J-S Vidal, J de Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
S Cook, P Vermersch, G Comi, et al.
La Revue De Medecine Interne
|
May 15, 2012
[Neuropsychiatric systemic lupus erythematosus (2nd part). Diagnostic and treatment tools in psychiatric or central nervous system manifestations in systemic lupus erythematosus]
G Lefèvre, H Zéphir, E Michelin, et al.
Page
of 22